PAUL S REMEDIOS

Allopathic & Osteopathic Physicians|Pediatrics METAIRIE, LA NPI 1730454059

General Payments — all program years on this page

$1,281.05

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 66
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $458.77 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $458.7720

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $99.556
2019 $125.428
2020 $51.243
2021 $148.098
2022 $240.1514
2023 $157.837
2024 $458.7720

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1082233036 Cranial Technologies, Inc $18.10 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082233038 Cranial Technologies, Inc $19.46 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100080737 Corium, LLC $26.40 03/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100134582 Corium, LLC $3.56 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100141487 Corium, LLC $2.05 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100144372 Corium, LLC $4.40 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100189795 Corium, LLC $24.24 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125627648 Seqirus USA Inc $18.84 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127040093 Kyowa Kirin, Inc. $28.35 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127040095 Kyowa Kirin, Inc. $13.07 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127040097 Kyowa Kirin, Inc. $13.60 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131400234 PFIZER INC. $22.97 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137661392 Takeda Pharmaceuticals U.S.A., Inc. $39.38 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139891472 GENZYME CORPORATION $21.80 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146261607 IRONSHORE PHARMACEUTICALS INC. $24.96 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147786454 Supernus Pharmaceuticals, Inc. $28.95 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147786456 Supernus Pharmaceuticals, Inc. $64.68 12/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147872100 Supernus Pharmaceuticals, Inc. $17.74 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147872102 Supernus Pharmaceuticals, Inc. $30.96 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147872104 Supernus Pharmaceuticals, Inc. $35.26 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.